About BIOXCEL THERAPEUTICS, INC.
BioXcel Therapeutics Inc is a biotechnology company focused on AI-based drug re-innovation, with products in development for conditions such as agitation associated with bipolar disorders or schizophrenia. The company operates in the pharmaceutical and medical affairs sectors.
AI-based drug re-innovationDevelopment of pharmaceutical products (e.g., IGALMI®)Clinical trials and researchMedical affairs and patient advocacy
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to BIOXCEL THERAPEUTICS, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.